Associate Director, Patient Marketing

Waltham, MA (Hybrid)

$195K/yr – $230K/yrSenior Level5+ years expFull time

Posted 4 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the end-to-end patient marketing engine by aligning cross-functional insights with a unified patient journey across systemic mastocytosis and GIST, while accelerating outcomes through digital ecosystems and AI-enabled tools.

  • Omnichannel ownership: design and manage an integrated patient education, engagement, activation, and adherence stack across branded and unbranded campaigns.
  • Cross-functional integration: translate patient insights into messaging and tools with Advocacy, PSP, and Market Access teams for a unified brand journey.
  • Digital ecosystem: build and optimize a branded patient website, paid search, social, CRM, and programmatic programs for high-impact education and activation.

Job Description

Responsibilities

  • Support the develop and execution of a comprehensive U.S. patient marketing strategy across the product lifecycle, including unbranded disease awareness and branded campaigns
  • Maintain and continuously refine the patient journey by identifying new inflection points, emotional hurdles, and barriers to treatment through ongoing insights collection
  • Support patient-focused market research, in collaboration with the market insights & patient advocacy teams, to ensure all brand messaging resonates with the lived experience of patients with systemic mastocytosis and GIST
  • Lead the creation of patient-facing materials and partner closely with the HCP Marketing and Sales teams to ensure patient resources are effectively utilized by the field in the clinical setting
  • Design and implement an integrated digital ecosystem (e.g., branded patient websites, paid search, social, CRM, programmatic) that supports education, engagement, activation, and treatment adherence
  • Track foundational metrics/KPIs and optimize performance in real-time
  • Develop and oversee data-driven omnichannel strategies for patients cross multiple disease states to ensure high-impact outreach and engagement, and a strong KPI-based evaluation and optimization
  • Ensure omnichannel plans align with brand strategy and launch plans and support HCP teams with omnichannel needs
  • Integrate innovations, including AI-enabled tools, to accelerate marketing outcomes
  • Lead the internal integration of patient insights across the organization, partnering with cross-functional teams to bridge the gap between clinical data and patient experience, ensuring a seamless and unified brand journey
  • Partner with Patient Advocacy, Patient Services and Market Access teams to build messaging and support tools that address education, affordability, reimbursement, and treatment continuity
  • Coordinate with the Patient Advocacy team to ensure brand strategies align with the broader goals of the Systemic Mastocytosis & GIST patient communities

Requirements

  • Bachelor’s degree required; Advanced degree (e.g., PharmD, MBA) preferred
  • Oncology and/or rare disease launch experience required
  • 5+ years of experience in pharmaceutical, biotech, or healthcare marketing, with 2+ years of experience in patient marketing
  • Proven success in digital patient marketing (web, social, SEO/SEM, CRM, and paid media strategy) and media planning and execution
  • Deep understanding of the patient journey and emotional drivers of behavior in rare disease and/or oncology disease populations
  • Experience collaborating with patient services (Patient Advocacy and PSP) to develop aligned messaging and support tools
  • Demonstrated ability to thrive in a fast-paced biotech environment
  • Location: Waltham, MA (surrounding areas) required
  • Travel required (up to 25%), including occasional weekends

Preferred

  • Global/US launch experience in oncology or rare disease is a plus
  • Experience with AI-enabled marketing tools or AI-enabled innovations in marketing would be beneficial
  • Prior experience collaborating with patient services (Patient Advocacy and PSP) to develop messaging and support tools beyond mandatory requirements

Benefits

  • benefits package that se t s us apart
  • We cover 100% of medical, dental, and vision premiums for you and your family
  • help reduce out-of-pocket costs by funding up to 75% of in-network deductibles
  • 401(k) match with immediate vesting
  • generous paid time off
  • 12 weeks of fully paid parental leave
  • paid family and medical leave for all employees regardless of location
  • company-paid short-term disability coverage for up to 20 weeks
  • wellness programs
  • tuition reimbursement
  • inclusive family-forming support
Cogent Biosciences logo

Cogent Biosciences

4.3 Glassdoor

Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has already exhibited promising early clinical activity and safety in a Phase 1/2 trial in patients with advanced GIST and also has the potential to fill an unmet need for patients living with Systemic Mastocytosis.

Founded in 2014
Waltham, Massachusetts, USA
251 employees (7 in marketing)
88% recommend to a friend
86% CEO approval

Traffic Signals

Monthly Visitors
12.1K
Traffic Source Mix
Search
37.1%
Direct
44.5%
Referral
6%
Social
11%
Paid
1.4%

Headcount Trend

Current headcount: ~252

Marketing Team

Marketing Team Size
7 (3% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$1.2B
Last Raise
Post IPO Equity, 8 months ago

Recent News